Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Philips & Pegasystems Team Up To Enhance Patient Care

Published 06/06/2016, 09:42 PM
Updated 07/09/2023, 06:31 AM

Koninklijke Philips N.V. (NYSE:PHG) recently collaborated with premium strategic business applications provider Pegasystems Inc. (NASDAQ:PEGA) to help health organizations utilize connected devices and sensitive customer data to offer personalized patient care.

A Boon for Healthcare

This collaboration is in the interest of managed care service providers and “accountable care organizations” that strive to improve health outcomes by relying on modern technology. The integration of Philips’ HealthSuite Cloud platform with Pegasystems’ Pega Care Management Application will help health care personnel identify potential health hazards and take preventive actions in a timely manner. Developed by Pegasystems, these latest connected health solutions are likely to be commercially available toward the end of the second half of this year.

Philips Cloud Platform

The Philips Cloud platform is well known for its state-of-the art predictive analytical expertise, linking millions of connected health devices and offering secured cloud storage and sharing of longitudinal patient data. The Philips and Pegasystems collaboration will allow patients to monitor their conditions on wearable devices and convey the same information to professional healthcare teams on a real-time basis, allowing time for quick response to critical patient needs.

The recent surge in the use of connected medical devices owing to changes in consumer lifestyle is acting as a primary catalyst for Philips’ Cloud platform. The increasing use of consumer wearables and sensors by consumers are encouraging major healthcare companies to harness the power of “Internet of Things” to boost healthcare quality, reduce readmissions and slash operational costs. This offers Philips ample opportunities to capitalize on its HealthSuite Cloud platform to maximize growth.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Our Take

Philips’ Healthcare segment emerged as one of the company’s primary growth drivers and the company is making concerted efforts to strengthen this segment further. Senior citizens make up for the chunk of the Healthcare segment’s customer base. Hence, we believe that an aging population and increasing healthcare expenditure in the years ahead will better Philips’ prospects.

Despite a strong foothold in the healthcare market, challenging market conditions, and mixed outlook in China, Russia and Latin America have dimmed the company’s prospects. Also, a sluggish macroeconomic outlook has marred the potential of the healthcare business which is expected to grow in low-single digits in 2016. This apart, escalating taxes and restructuring charges associated with the Lighting business are proving to be major headwinds over the near term,, dealing heavy blow to its bottom line. Going forward, the company forecasts discontinued operations and separation costs in the range of €200–€300 million and restructuring costs of €50 million. These challenges are expected to impact this Zacks Rank #4 (Sell) company’s 2016 EBITA by €80–€100 million.

Some better-ranked stocks in the same space include Jason Industries, Inc. (NASDAQ:JASN) and Kopin Corporation (NASDAQ:KOPN) , both holding a Zacks Rank #2 (Buy).



PEGASYSTEMS INC (PEGA): Free Stock Analysis Report

KONINKLIJKE PHL (PHG): Free Stock Analysis Report

KOPIN CORP (KOPN): Free Stock Analysis Report

JASON INDUSTRS (JASN): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.